4Hatzidaki D,Agelaki S,Mavroudis D. A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancer[J].Clin Lung Cancer,2006,(01):49-55.
5Yoshida K,Sugiura T,Takifuji N. Randomized phase Ⅱ trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer:JCOG 9515[J].{H}Lung Cancer,2007,(03):362-368.
6Cusumano G,Margarifora S,Porziella V. Malignant Pleural Effusion[J].{H}Annali Italiani Di Chirurgia,2007,(05):389-391.
7Ebert W,Hoppe M,Muley T. Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA21-1,TPATP CEA and NSE[J].Anti Cancer Res,1997,(04):2875-2877.
8Mariam EZ,Marie EP,Jack S,et al.History of allergic diseases and lung cancer risk[J].Annals of Allergy,Asthma&Immunology,2013,(11):398-765.
9Ritu R,Gill,Michael T,et al.Controversies in Lung Cancer Screening[J].Journal of the American College of Radiology,2013,1012(8):487-875.
